{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:21:39Z","timestamp":1793949699781,"version":"4.8.0"},"posted":{"date-parts":[[2025,3,31]]},"group-title":"In Review","reference-count":50,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,3,5]]},"abstract":"<title>Abstract<\/title>\n        <p>Elevated anti-citrullinated protein antibodies (ACPA) levels in the peripheral blood are associated with an increased risk for developing rheumatoid arthritis (RA). Currently, no treatments are available that prevent progression to RA in these at-risk individuals. In addition, diverse pathogenic mechanisms underlying a common clinical phenotype in RA complicate therapy as no single agent is universally effective. We propose that a unifying set of transcription factor and their downstream pathways regulate a pro-inflammatory cell communication network, and that this network allows multiple cell types to serve as pathogenic drivers in at-risk individuals and in early RA. To test this hypothesis, we identified ACPA-positive at-risk individuals, patients with early ACPA-positive RA and matched controls. We measured single cell chromatin accessibility and transcriptomic profiles from their peripheral blood mononuclear cells. The datasets were then integrated to define key TF, as well as TF-regulated targets and pathways. A distinctive TF signature was enriched in early RA and at-risk individuals that involved key pathogenic mechanisms in RA, including SUMOylation, RUNX2, YAP1, NOTCH3, and \u03b2-Catenin Pathways. Interestingly, this signature was identified in multiple cell types, including T cells, B cells, and monocytes, and the pattern of cell type involvement varied among the at-risk and early RA participants, supporting our hypothesis. Similar patterns of individualized gene expression patterns and cell types were confirmed in single cell studies of RA synovium. Cell communication analysis provided biological validation that diverse lineages can deliver the same core set of pro-inflammatory mediators to receiver cells <italic>in vivo<\/italic> that subsequently orchestrate rheumatoid inflammation. These cell-type-specific signature pathways could explain the personalized pathogenesis of RA and contribute to the diversity of clinical responses to targeted therapies. Furthermore, these data could provide opportunities for stratifying individuals at-risk for RA, and selecting therapies tailored for prevention or treatment of RA. Overall, this study supports a new paradigm to understand how a common clinical phenotype could arise from diverse pathogenic mechanisms and demonstrates the relevance of peripheral blood cells to synovial disease.<\/p>","DOI":"10.21203\/rs.3.rs-6165802\/v1","type":"posted-content","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T13:51:57Z","timestamp":1743429117000},"source":"Crossref","is-referenced-by-count":1,"title":["Multi-lineage transcriptional and cell communication signatures define pathways in individuals at-risk for developing rheumatoid arthritis that initiate and perpetuate disease"],"prefix":"10.21203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4377-5060","authenticated-orcid":false,"given":"Wei","family":"Wang","sequence":"first","affiliation":[{"name":"UCSD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4958-7856","authenticated-orcid":false,"given":"Cong","family":"Liu","sequence":"additional","affiliation":[{"name":"University of California San Deigo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Firestein","sequence":"additional","affiliation":[{"name":"University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8965-5326","authenticated-orcid":false,"given":"Peter","family":"Skene","sequence":"additional","affiliation":[{"name":"Allen Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Deane","sequence":"additional","affiliation":[{"name":"UCDenver"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Holers","sequence":"additional","affiliation":[{"name":"University of Colorado School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9005-1885","authenticated-orcid":false,"given":"Jane","family":"Buckner","sequence":"additional","affiliation":[{"name":"Benaroya Research Institute at Virginia Mason"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"1. Gravallese, E. M. & Firestein, G. S. Rheumatoid Arthritis - Common Origins, Divergent Mechanisms. N. Engl. J. Med. 388, (2023).","DOI":"10.1056\/NEJMra2103726"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"2. Holers, V. M. et al. Mechanism-driven strategies for prevention of rheumatoid arthritis. Rheumatology & autoimmunity 2, 109\u2013119 (2022).","DOI":"10.1002\/rai2.12043"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"3. Holers, V. M. et al. Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction. Nat. Rev. Rheumatol. 14, 542\u2013557 (2018).","DOI":"10.1038\/s41584-018-0070-0"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"4. van Boheemen, L. et al. Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial. RMD open 7, e001591 (2021).","DOI":"10.1136\/rmdopen-2021-001591"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"5. Gerlag, D. M. et al. Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study. Ann. Rheum. Dis. 78, 179\u2013185 (2019).","DOI":"10.1136\/annrheumdis-2017-212763"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"6. Krijbolder, D. I. et al. Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial. Lancet 400, 283\u2013294 (2022).","DOI":"10.1016\/S0140-6736(22)01193-X"},{"key":"ref7","unstructured":"7. Deane K, Striebich C, Feser M, Demoruelle K, Moss L, Bemis E, Frazer-Abel A, Fleischer C, Sparks J, Solow E, James J, Guthridge J, Davis J, Graf J, Kay J, Danila M, Bridges, Jr. S, Forbess L, O\u2019Dell J, McMahon M, Grossman J, Horowitz D, Tiliakos A, Schiopu E, Fox D, Carlin J, Arriens C, Bykerk V, Jan R, Pioro M, Husni M, Fernandez-Pokorny A, Walker S, Booher S, Greenleaf M, Byron M, Keyes-Elstein L, Goldmuntz E, Holers V. Hydroxychloroquine Does Not Prevent the Future Development of Rheumatoid Arthritis in a Population with Baseline High Levels of Antibodies to Citrullinated Protein Antigens and Absence of Inflammatory Arthritis: Interim Analysis of the StopRA Trial. ARTHRITIS & RHEUMATOLOGY. 74, 3180\u20133182 (2022)."},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"8. Rech, J. et al. Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial. Lancet 403, 850\u2013859 (2024).","DOI":"10.1016\/S0140-6736(23)02650-8"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"9. Weinand, K. et al. The chromatin landscape of pathogenic transcriptional cell states in rheumatoid arthritis. Nature Communications 15, 4650 (2024).","DOI":"10.1101\/2023.04.07.536026"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"10. Zhang, F. et al. Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat Immunol 20, 928\u2013942 (2019).","DOI":"10.1038\/s41590-019-0378-1"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"11. Zhang, F. et al. Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes. Nature 623, 616\u2013624 (2023).","DOI":"10.1038\/s41586-023-06708-y"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"12. Zhang, K., Wang, M., Zhao, Y. & Wang, W. Taiji: System-level identification of key transcription factors reveals transcriptional waves in mouse embryonic development. Sci Adv 5, eaav3262 (2019).","DOI":"10.1126\/sciadv.aav3262"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"13. Liu, C. et al. Systems-level identification of key transcription factors in immune cell specification. PLoS Comput. Biol. 18, e1010116 (2022).","DOI":"10.1371\/journal.pcbi.1010116"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"14. Chung, H. K. et al. Multiomics atlas-assisted discovery of transcription factors enables specific cell state programming. bioRxiv (2023).","DOI":"10.1101\/2023.01.03.522354"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"15. Yu, B. et al. Epigenetic landscapes reveal transcription factors that regulate CD8 T cell differentiation. Nature Immunology 18, 573\u2013582 (2017).","DOI":"10.1038\/ni.3706"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"16. Feinberg, M. W. et al. The Kruppel-like factor KLF4 is a critical regulator of monocyte differentiation. EMBO J. 26, 4138\u20134148 (2007).","DOI":"10.1038\/sj.emboj.7601824"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"17. Intlekofer, A. M. et al. Effector and memory CD8\u2009+\u2009T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 6, 1236\u20131244 (2005).","DOI":"10.1038\/ni1268"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"18. Dehnavi, S. et al. The role of protein SUMOylation in rheumatoid arthritis. J. Autoimmun. 102, 1\u20137 (2019).","DOI":"10.1016\/j.jaut.2019.05.006"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"19. Di Chen, Dongyeon J Kim, Jie Shen, Zhen Zou, Regis J O\u2019Keefe. Runx2 plays a central role in Osteoarthritis development. Journal of Orthopaedic Translation 23, 132\u2013139 (2020).","DOI":"10.1016\/j.jot.2019.11.008"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"20. Caire, R. et al. YAP\/TAZ: Key Players for Rheumatoid Arthritis Severity by Driving Fibroblast Like Synoviocytes Phenotype and Fibro-Inflammatory Response. Front. Immunol. 12, 791907 (2021).","DOI":"10.3389\/fimmu.2021.791907"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"21. Zhuang, Y. et al. A narrative review of the role of the Notch signaling pathway in rheumatoid arthritis. Annals of Translational Medicine 10, 371\u2013371 (2022).","DOI":"10.21037\/atm-22-142"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"22. Chen, S. et al. Wnt\/\u03b2-catenin signaling pathway promotes abnormal activation of fibroblast-like synoviocytes and angiogenesis in rheumatoid arthritis and the intervention of Er Miao San. Phytomedicine 120, 155064 (2023).","DOI":"10.1016\/j.phymed.2023.155064"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"23. Vecellio, M., Cohen, C. J., Roberts, A. R., Wordsworth, P. B. & Kenna, T. J. RUNX3 and T-Bet in Immunopathogenesis of Ankylosing Spondylitis\u2014Novel Targets for Therapy? Front. Immunol. 9, 424898 (2018).","DOI":"10.3389\/fimmu.2018.03132"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"24. Jin, S. et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun. 12, 1\u201320 (2021).","DOI":"10.1038\/s41467-021-21246-9"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"25. Serum proteomic analysis identifies interleukin 16 as a biomarker for clinical response during early treatment of rheumatoid arthritis. Cytokine 78, 87\u201393 (2016).","DOI":"10.1016\/j.cyto.2015.12.002"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"26. Galea, C. A., Nguyen, H. M., George Chandy, K., Smith, B. J. & Norton, R. S. Domain structure and function of matrix metalloprotease 23 (MMP23): role in potassium channel trafficking. Cell. Mol. Life Sci. 71, 1191\u20131210 (2013).","DOI":"10.1007\/s00018-013-1431-0"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"27. Cohen, S. B. et al. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks. Arthritis Rheum. 54, 2793\u20132806 (2006).","DOI":"10.1002\/art.22025"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"28. Genovese, M. C. et al. Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor \u03b1 Inhibition. New England Journal of Medicine 353, 1114\u20131123 (2005).","DOI":"10.1056\/NEJMoa050524"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"29. Stefana Alivernini, Gary S Firestein, Iain B Mclnnes. The pathogenesis of rheumatoid arthritis. Immunity 55, 2255\u20132270 (2022).","DOI":"10.1016\/j.immuni.2022.11.009"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"30. Choi, E. et al. Joint-specific rheumatoid arthritis fibroblast-like synoviocyte regulation identified by integration of chromatin access and transcriptional activity. JCI Insight 9, e179392 (2024).","DOI":"10.1172\/jci.insight.179392"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"31. Binvignat, M. et al. Single-cell RNA-Seq analysis reveals cell subsets and gene signatures associated with rheumatoid arthritis disease activity. JCI Insight 9, e178499 (2024).","DOI":"10.1172\/jci.insight.178499"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"32. Inamo, J. et al. Deep immunophenotyping reveals circulating activated lymphocytes in individuals at risk for rheumatoid arthritis. bioRxiv 2023.07.03.547507 (2023) doi:10.1101\/2023.07.03.547507.","DOI":"10.1101\/2023.07.03.547507"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"33. He, Z. et al. Systemic inflammation and lymphocyte activation precede rheumatoid arthritis. Preprint at https:\/\/doi.org\/10.1101\/2024.10.25.620344 (2024).","DOI":"10.1101\/2024.10.25.620344"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"34. Moreland, L. W. et al. Double-blind, placebo-controlled multicenter trial using chimeric monoclonal anti-CD4 antibody, cM-T412, in rheumatoid arthritis patients receiving concomitant methotrexate. Arthritis Rheum 38, 1581\u20131588 (1995).","DOI":"10.1002\/art.1780381109"},{"key":"ref35","unstructured":"35. Joehanes, R. et al. Epigenetic Signatures of Cigarette Smoking. Circ. Cardiovasc. Genet. 9, 436\u2013447 (2016)."},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"36. James, E. A. et al. Multifaceted immune dysregulation characterizes individuals at-risk for rheumatoid arthritis. Nat. Commun. 14, 7637 (2023).","DOI":"10.1038\/s41467-023-43091-8"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"37. Warren, R. B. et al. Long-Term Efficacy and Safety of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: Updated Systematic Literature Review and Network Meta-analysis. Dermatol Ther (Heidelb) 14, 3133\u20133147 (2024).","DOI":"10.1007\/s13555-024-01302-0"},{"key":"ref38","unstructured":"38. Aletaha, D. et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 62, 2569\u20132581 (2010)."},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"39. Swanson, E. et al. Simultaneous trimodal single-cell measurement of transcripts, epitopes, and chromatin accessibility using TEA-seq.\u00a0Elife 10, e63632 (2021).","DOI":"10.7554\/eLife.63632"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"40. Swanson, E., Reading, J., Graybuck, L. T. & Skene, P. J. BarWare: efficient software tools for barcoded single-cell genomics. BMC Bioinformatics 23, 106 (2022).","DOI":"10.1186\/s12859-022-04620-2"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"41. Yuhan Hao, Stephanie Hao, Erica Andersen-Nissen, William M. Mauck, Shiwei Zheng, Andrew Butler, Maddie J. Lee, Aaron J. Wilk, Charlotte Darby, Michael Zager, Paul Hoffman, Marlon Stoeckius, Efthymia Papalexi, Eleni P. Mimitou, Jaison Jain, Avi Srivastava, Tim Stuart, Lamar M. Fleming, Bertrand Yeung, Angela J. Rogers, Juliana M. McElrath, Catherine A. Blish, Raphael Gottardo, Peter Smibert, Rahul Satija. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 (2021).","DOI":"10.1016\/j.cell.2021.04.048"},{"key":"ref42","unstructured":"42. Weirauch, M. T. et al. Determination and inference of eukaryotic transcription factor sequence specificity. Cell 158, (2014)."},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"43. Zhu, Y. et al. Constructing 3D interaction maps from 1D epigenomes. Nat. Commun. 7, 10812 (2016).","DOI":"10.1038\/ncomms10812"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"44. Kuhn, M. Building Predictive Models in R Using the caret Package. J. Stat. Softw. 28, 1\u201326 (2008).","DOI":"10.18637\/jss.v028.i05"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"45. Ainsworth, R. I. et al. Systems-biology analysis of rheumatoid arthritis fibroblast-like synoviocytes implicates cell line-specific transcription factor function. Nat. Commun. 13, 1\u201311 (2022).","DOI":"10.1038\/s41467-022-33785-w"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"46. Hilton, M. J. et al. Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nat. Med. 14, 306\u2013314 (2008).","DOI":"10.1038\/nm1716"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"47. Wei, K. et al. Notch signaling drives synovial fibroblast identity and arthritis pathology. Nature 582, 259\u2013264 (2020).","DOI":"10.1038\/s41586-020-2222-z"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"48. Bottini, A. et al. PTPN14 phosphatase and YAP promote TGF\u03b2 signalling in rheumatoid synoviocytes. Ann. Rheum. Dis. 78, 600\u2013609 (2019).","DOI":"10.1136\/annrheumdis-2018-213799"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"49. Ma, B. & Hottiger, M. O. Crosstalk between Wnt\/\u03b2-Catenin and NF-\u03baB Signaling Pathway during Inflammation. Front. Immunol. 7, 221254 (2016).","DOI":"10.3389\/fimmu.2016.00378"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"50. Nagata, K. et al. Runx2 and Runx3 differentially regulate articular chondrocytes during surgically induced osteoarthritis development. Nat. Commun. 13, 6187 (2022).","DOI":"10.1038\/s41467-022-33744-5"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6165802\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6165802\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T08:56:24Z","timestamp":1747385784000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-6165802\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,31]]},"references-count":50,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-6165802\/v1","relation":{},"subject":[],"published":{"date-parts":[[2025,3,31]]},"subtype":"preprint"}}